marijuana stocks news

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medbox, Inc. Stockholders

NEW YORK–(BUSINESS WIRE)–

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medbox, Inc. (“Medbox” or the “Company”) (MDBX) concerning its disclosure of misleading financial statements.

In October 2014, the Company appointed a special board committee which would investigate a federal grand jury subpoena served upon the Company’s accountants, in addition to certain alleged wrongdoing raised by a former employee of the Company. Medbox has since received subpoenas from the federal grand jury and the Securities and Exchange Commission. Upon its investigation, on December 30, 2014, Medbox announced that its financial statements for the year ended December 31, 2013, the third and fourth quarters of 2013, and the first three quarters of 2014 will have to be amended and restated. As part of the Company’s internal investigation it will also review its financial statements for 2012 and the first two quarters of 2013.

If you are a Medbox stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email atbwalker@kmllp.com, or telephone at (212) 699-1145, Melissa Fortunato, Esq. by email atmfortunato@kmllp.com, or telephone at (212) 699-1141, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Contact:
Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145
bwalker@kmllp.com
or
Melissa Fortunato, Esq., 212-699-1141
mfortunato@kmllp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Greenlane Holdings, Inc. (GNLN) to Launch Fentanyl, Xylazine and Drink Spike Detection Test Strips Product Line

Greenlane to Launch Fentanyl, Xylazine and Drink Spike Detection Test Strips Product…

Green Thumb Industries Inc.(GTBIF) Raises US$56,000,000 Selling Approximately 1.6 Million Shares in the U.S.

Green Thumb Industries Raises US$56,000,000 Selling Approximately 1.6 Million Shares in the…

Tetra Bio-Pharma (TBPMF) Clinical Study on Cannabis Oil Capsules for Patients Suffering from Chronic Pain should be completed by Fall 2018

OTTAWA, ONTARIO–(Marketwired – Apr 12, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or…